While I am totally thrilled with the Ann I am wondering how are we able to go straight to phase 2 human trials? When did the company develop the medicine?
Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint